Connect with us

News

Turkish Healthcare Startup RS Research Uses Nanotech To Selectively Destroy Tumors

The startup designed a nanotechnology platform for highly targeted delivery of drugs directly to cancer cells.

Published

on

turkish healthcare startup rs research uses nanotech to selectively destroy tumors
Unsplash

All currently available types of treatment for cancer leave a lot to be desired — both in terms of their effectiveness and side effects. Chemotherapy, for example, is effective at preventing cancer from spreading to other parts of the body and even capable of eliminating it entirely, but it can’t tell the difference between cancer cells and healthy cells. Turkish healthcare startup RS Research strongly believes that it has the recipe for significantly increasing the effectiveness of drug-based cancer treatments like chemotherapy.

The startup designed a nanotechnology platform for highly targeted delivery of drugs directly to cancer cells. The platform is called Sagitta, and the name comes from the Latin word for “arrow.”

“Sagitta platform is a groundbreaking technology approach utilizing Polymer Drug Conjugates to target the tumor with a high payload of cytotoxins; resulting in high efficacy with reduced side-effect profile. In addition to moving our own candidates through clinical development, Sagitta platform is available for co-development projects,” explains RS Research on its website.

In other words, Sagitta allows drugs to do their job with minimal side effects, making it possible to avoid causing damage to healthy cells. If everything goes right, the technology could be used to support cancer treatment in Turkey and beyond as early as 2024.

Also Read: FDA Approves Israeli Cancer-Freezing Technology

Together with other innovative cancer treatments, such as gene therapy, hormone replacement therapy, and immunotherapy, scientists and doctors are gradually expanding the range of treatment options available to cancer patients, and we can only hope that a real cure isn’t too far away.

Not too long ago, the FDA approved an Israeli medical technology after demonstrating its ability to eliminate tumors using new cancer-freezing technology.

The COVID-19 pandemic has greatly accelerated many areas of medical research, and it would be a welcome turn of events if some coronavirus-related findings helped finally defeat cancer.

Advertisement

📢 Get Exclusive Monthly Articles, Updates & Tech Tips Right In Your Inbox!

JOIN 17K+ SUBSCRIBERS

Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

News

Initial Trials Of Dubai’s Driverless Evocargo Trucks Completed

Testing was announced on July 17, and the completion is a major milestone towards upgrading the region’s logistics infrastructure.

Published

on

initial trials of dubai's driverless evocargo trucks completed
Dubai Media Office

A Dubai-based company has completed the initial trials for the UAE’s first driverless trucks. The groundbreaking achievement by Evocargo, partnering with Dubai South, took place at Dubai South Logistics District, and marked a significant step towards incorporating autonomous technologies into the region’s wider logistics infrastructure.

Announced on Wednesday, July 17th, the trials featured the Evocargo N1 unmanned electric truck navigating a predetermined route within a controlled setting. The test involved interactions with common road obstacles such as cars, trucks, and pedestrians, aiming to evaluate the vehicle’s hardware and software reliability, accident prevention systems, and overall readiness for public road use.

Officials were keen to highlight that this accomplishment aligns with the UAE’s ambitious strategy to position itself as a global leader in innovation and technology adoption. The country aims to have 25% of all transportation in Dubai autonomous by 2030, underscoring its commitment to revolutionizing the logistics sector using advanced technologies.

Mohsen Ahmad, CEO of the Logistics District at Dubai South, emphasized the importance of the collaboration with Evocargo in enhancing the region’s logistics capabilities. He noted that autonomous vehicles are set to increase efficiency, reduce carbon emissions, and establish a sustainable logistics infrastructure that will benefit both Dubai and the wider UAE.

Also Read: Riyadh Developers Reveal New 45,000-Seat Murabba Stadium

Ahmed Al-Ansi, CEO of Evocargo Autonomous Logistic Services, also expressed optimism that the trials will draw new customers and investments across the Gulf Cooperation Council (GCC) countries. The partnership aims to lead in innovative tech solutions, further establishing the UAE as a pioneer in autonomous transportation.

The successful completion of the trials marks a crucial step towards realizing the UAE’s vision for a technologically advanced and sustainable future in which autonomous vehicles are expected to play a pivotal role in global logistics.

Continue Reading

#Trending